BioRestorative Therapies, Inc. (BRTX) Financials
BRTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 4.6 million | 1.6 million |
| Dec. 31, 2025 | 4.1 million | 3.7 million |
| Sept. 30, 2025 | 5.6 million | 3.4 million |
| June 30, 2025 | 8.5 million | 3.7 million |
BRTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -3.8 million | 290215 |
| Dec. 31, 2025 | -2.5 million | 447860 |
| Sept. 30, 2025 | -2.9 million | 399932 |
| June 30, 2025 | -2.7 million | 468708 |
BRTX Net Income
No data available :(
BRTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 3.6 million | - | - |
| Dec. 31, 2025 | 3.0 million | - | - |
| Sept. 30, 2025 | 4.5 million | - | - |
| June 30, 2025 | 7.4 million | - | - |
BRTX Shares Outstanding
BRTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 1.9 million | 1.5 million | - |
| Dec. 31, 2025 | 79669 | 2.6 million | 1.2 million | - |
| Sept. 30, 2025 | 3 | 2.6 million | 1.1 million | - |
| June 30, 2025 | - | 2.2 million | 1.4 million | - |
BRTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 23170 | 7385 |
| Dec. 31, 2025 | 19600 | 1636 |
| Sept. 30, 2025 | 11800 | 10570 |
| June 30, 2025 | 303300 | 8729 |
BRTX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BRTX
Price: $0.41
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.06 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 19500
Market Capitalization: 3.6 million